Literature DB >> 16339696

Osteoporosis in beta-thalassemia: Clinical and genetic aspects.

R Origa1, E Fiumana, M R Gamberini, S Armari, M Mottes, A Sangalli, E Paglietti, R Galanello, C Borgna-Pignatti.   

Abstract

Osteoporosis and osteopenia are frequent complications of thalassemia major (TM) and intermedia (TI). Osteoporosis was found in 23/25 patients with TI and in 115/239 patients with TM. In TM, no association was found with specific polymorphisms in candidate genes (vitamin D receptor, estrogen receptor, calcitonin receptor, and collagen type 1 alpha 1). Osteoporosis in female patients with TM was strongly associated with primary amenorrhea (P < .0001), while in male patients with TM, hypogonadism was not significantly related to bone mineral density (BMD) (P = .0001). Low BMD was also associated with cardiomiopathy (P = .01), diabetes mellitus (P = .0001), chronic hepatitis (P = .0029), and increased ALT (P = .01).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339696     DOI: 10.1196/annals.1345.051

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Bone disease in adult patients with β-thalassaemia major: a case-control study.

Authors:  Marina Baldini; Stella Forti; Alessandra Orsatti; Fabio Massimo Ulivieri; Lorena Airaghi; Laura Zanaboni; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2011-12-17       Impact factor: 3.397

2.  Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.

Authors:  Rashid Merchant; Amish Udani; Vipla Puri; Valentina D'cruz; Deepak Patkar; Aarti Karkera
Journal:  Indian J Pediatr       Date:  2010-08-25       Impact factor: 1.967

3.  Dual-energy X-ray absorptiometry with serum ferritin predicts liver iron concentration and changes in concentration better than ferritin alone.

Authors:  John A Shepherd; Bo Fan; Ying Lu; Lorena Marquez; Khaled Salama; Jimmy Hwang; Ellen B Fung
Journal:  J Clin Densitom       Date:  2010-07-21       Impact factor: 2.617

4.  Osteoporosis syndrome in thalassaemia major: an overview.

Authors:  Meropi Toumba; Nicos Skordis
Journal:  J Osteoporos       Date:  2010-05-26

Review 5.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822

6.  Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: Evidence via meta-analysis.

Authors:  Shouyi Li; Huiqiang Jiang; Ningke Du
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

7.  SAA1 gene polymorphisms in osteoporosis patients.

Authors:  Xindie Zhou; Jin Li; Lifeng Jiang; Dong Zhou; Lidong Wu; Yong Huang; Nanwei Xu
Journal:  Biosci Rep       Date:  2019-02-19       Impact factor: 3.840

Review 8.  A contemporary therapeutic approach to bone disease in beta-thalassemia - a review.

Authors:  Dimitrios Stefanopoulos; Nikolaos A Papaioannou; Athanassios G Papavassiliou; George Mastorakos; Andromachi Vryonidou; Aikaterini Michou; Ismene A Dontas; George Lyritis; Eva Kassi; Symeon Tournis
Journal:  J Frailty Sarcopenia Falls       Date:  2018-03-01

9.  Bone disease in thalassemia: a frequent and still unresolved problem.

Authors:  Maria G Vogiatzi; Eric A Macklin; Ellen B Fung; Angela M Cheung; Elliot Vichinsky; Nancy Olivieri; Melanie Kirby; Janet L Kwiatkowski; Melody Cunningham; Ingrid A Holm; Joseph Lane; Robert Schneider; Martin Fleisher; Robert W Grady; Charles C Peterson; Patricia J Giardina
Journal:  J Bone Miner Res       Date:  2009-03       Impact factor: 6.741

10.  Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ß-thalassemia in upper Egypt (single center study).

Authors:  Gehan L Abdel Hakeem; Suzan O Mousa; Asmaa N Moustafa; Mohamed H Mahgoob; Ebtesam E Hassan
Journal:  Health Qual Life Outcomes       Date:  2018-04-10       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.